Found: 9
Select item for more details and to access through your institution.
Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn's disease, a post hoc analysis.
- Published in:
- Therapeutic Advances in Gastroenterology, 2019, v. 12, p. N.PAG, doi. 10.1177/1756284819881590
- By:
- Publication type:
- Article
Precise Longitudinal Tracking of Microscopic Structures in Melanocytic Nevi Using Reflectance Confocal Microscopy: A Feasibility Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II Study.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 3, p. 341, doi. 10.1093/ecco-jcc/jjad156
- By:
- Publication type:
- Article
Dose optimisation for Loss of Response to Vedolizumab— Pharmacokinetics and Immune Mechanisms.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 10, p. 1707, doi. 10.1093/ecco-jcc/jjab067
- By:
- Publication type:
- Article
Vedolizumab Levels in Breast Milk of Nursing Mothers With Inflammatory Bowel Disease.
- Published in:
- Journal of Crohn's & Colitis, 2018, v. 12, n. 1, p. 120, doi. 10.1093/ecco-jcc/jjx120
- By:
- Publication type:
- Article
Middle small-bowel segment Lewis score may predict long-term outcomes among patients with quiescent Crohn's disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, p. 1, doi. 10.1177/17562848231188587
- By:
- Publication type:
- Article
Middle small-bowel segment Lewis score may predict long-term outcomes among patients with quiescent Crohn's disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, v. 16, p. 1, doi. 10.1177/17562848231188587
- By:
- Publication type:
- Article
Delaying an infliximab infusion by more than 3 days is associated with a significant reduction in trough levels but not with clinical worsening.
- Published in:
- Therapeutic Advances in Gastroenterology, 2022, v. 15, p. 1, doi. 10.1177/17562848221083395
- By:
- Publication type:
- Article
Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal Adenocarcinoma.
- Published in:
- Clinical & Translational Gastroenterology, 2022, v. 13, n. 5, p. e00473, doi. 10.14309/ctg.0000000000000473
- By:
- Publication type:
- Article